Peanut Allergy Therapy Scores Late-stage Trial Win

Feb 20, 2018, 16:36 by Michael Croft

STAT | Based on the positive results, Aimmune Therapeutics expects to seek U.S. approval for its preventative peanut allergy therapy by the end of the year, with a European filing in 2019, the company said.

February 20, 2018 | Based on the positive results, Aimmune Therapeutics expects to seek U.S. approval for its preventative peanut allergy therapy by the end of the year, with a European filing in 2019, the company said. STAT